Clinical Trial

Creatine Supplementation During GLP-1a Therapy

Name: Creatine Supplementation During GLP-1a Therapy — clinical trial record (NCT07625202)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

GLP-1 receptor agonists are effective for weight loss, but significant muscle mass is lost as a proportion of this weight loss. This study combines resistance-training and creatine supplementation to try to prevent this loss of muscle mass.

Trial Details

NCT Number	NCT07625202
Lead Sponsor	University of Saskatchewan
Conditions	Sarcopenia
Enrollment	40 participants
Start Date	2026-05-25
Primary Completion	2027-05-30 (estimated)
Study Completion	2027-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-06-04